HALAVEN is an FDA-approved chemotherapy that offers an opportunity to live longer for women whose metastatic breast cancer (mBC) has progressed after at least 2 types of mBC therapy. Previous therapy should have included an anthracycline and a taxane for either early or advanced breast cancer.
HALAVEN is developed from a natural substance found in a sea sponge, and is the only medicine discovered in its class of chemotherapy. Based on early laboratory studies, HALAVEN works by limiting the growth of cancer cells, and ultimately killing them.
HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.
HALAVEN can cause serious side effects, including
Before you receive HALAVEN, tell your health care provider about all of your medical conditions, including if you
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of HALAVEN?
HALAVEN can cause changes in your heartbeat (called QT prolongation). This can cause irregular heartbeats. Your health care provider may do heart monitoring (electrocardiogram or ECG) or blood tests during your treatment with HALAVEN to check for heart problems.
The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.
Your health care provider will do blood tests before and during treatment while you are taking HALAVEN.
For more information about HALAVEN, please see full Prescribing Information.